2020
DOI: 10.1016/j.ultrasmedbio.2020.05.019
|View full text |Cite|
|
Sign up to set email alerts
|

Development of 64Cu-loaded Perfluoropentane Nanodroplet: A Potential Tumor Theragnostic Nano-carrier and Dual-Modality PET-Ultrasound Imaging Agents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 39 publications
0
1
0
Order By: Relevance
“…To overcome the disadvantages of ultrasound contrast agents, PFP and 64 Cucoloaded phospholipid-shelled nanodroplets were developed as potential contrast agents, contributing to tumor diagnosis by fusing nuclear medicine and ultrasound. 177 Recently, Wang and colleagues structured a caspase-3-activatable [ 18 F]-IR780-1 as the PA/PET bimodal probe through in situ self-assembly and macrocyclization of small molecules to reflex the apoptosis in tumors (Figure 37a). 199 Higher PET and PA signal intensities were found in apoptotic cell suspensions compared to viable or apoptosis-suppressed cells (Figure 37b, c).…”
Section: Multi-modality Imagingmentioning
confidence: 99%
See 1 more Smart Citation
“…To overcome the disadvantages of ultrasound contrast agents, PFP and 64 Cucoloaded phospholipid-shelled nanodroplets were developed as potential contrast agents, contributing to tumor diagnosis by fusing nuclear medicine and ultrasound. 177 Recently, Wang and colleagues structured a caspase-3-activatable [ 18 F]-IR780-1 as the PA/PET bimodal probe through in situ self-assembly and macrocyclization of small molecules to reflex the apoptosis in tumors (Figure 37a). 199 Higher PET and PA signal intensities were found in apoptotic cell suspensions compared to viable or apoptosis-suppressed cells (Figure 37b, c).…”
Section: Multi-modality Imagingmentioning
confidence: 99%
“…As for PET, 64 Cu, and 18 F have been reported for dual-modality imaging with ultrasound. To overcome the disadvantages of ultrasound contrast agents, PFP and 64 Cu-coloaded phospholipid-shelled nanodroplets were developed as potential contrast agents, contributing to tumor diagnosis by fusing nuclear medicine and ultrasound . Recently, Wang and colleagues structured a caspase-3-activatable [ 18 F]-IR780-1 as the PA/PET bimodal probe through in situ self-assembly and macrocyclization of small molecules to reflex the apoptosis in tumors (Figure a) .…”
Section: Ultrasound-based Micro-/nanosystems For Biomedical Imagingmentioning
confidence: 99%
“…Another phospholipid-shelled nanodroplets encapsulating perfluoropentane (PFP) with copper-64 ( 64 Cu) labeled were evaluated for PET/CT and ultrasound imaging. 81 These nanomaterials contribute to the diagnosis by fusing the science and technology of different imaging modalities. Shi et al designed the mesoporous silica gadolinium-loaded gap-enhanced Raman tags for both preoperative and intraoperative imaging.…”
Section: Nanoparticles Designed For the Imaging Of Gastric Cancermentioning
confidence: 99%